3 trials - Govindan - Reck - phase 2 (phased ipilimumab)
Adjuvant 1 - NOVARTIS: 1 trials - EORTC 18071 (Eggermont)
Adjuvant setting: 1 trials - EORTC 18071 (Eggermont)
Adjuvant stage III only - NOVARTIS : 1 trials - EORTC 18071 (Eggermont)
All type of patients: 4 trials - EORTC 18071 (Eggermont) - Robert - Hodi (ipi + gp100) - Hodi (ipi alone)
First line : 1 trials - Robert
Second line (or later): 2 trials - Hodi (ipi + gp100) - Hodi (ipi alone)